Elena Viboch, partner at General Catalyst, discusses her predictions for biotech and health tech investing and how startups can grow in a more constrained economic environment.
/PRNewswire/ Vial, a faster, better, cheaper CRO powered by technology, announced today that they have raised over $100M in cumulative equity funding since.
Odyssey Therapeutics Announces Oversubscribed $168 Million Series B Financing streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Deep Genomics raises $180m to advance drugs for genetic diseases pharmaceutical-technology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceutical-technology.com Daily Mail and Mail on Sunday newspapers.